INDmoney
Sun Pharmaceutical Share Price
₹1623.00
+12.90
(+0.80%)
as on
🔔 Earnings Alert
Sun Pharma reported a 16% Y-o-Y profit increase for Q3FY26, driven by new product launches and strong performance across markets.
Sun Pharmaceutical Stock Performance
as on February 2, 2026 at 1:43 pm IST
Day's Low
Day's High
₹1,598.20₹1,634.00
1.53%
Downside
0.68%
Upside
52 Week's Low
52 Week's High
₹1,548.00₹1,851.204.62%
Downside
14.06%
Upside
Sun Pharmaceutical share price movements today
- Previous Close
- ₹1,610.10
- Open
- ₹1,621.80
- Volume
- 18.44L
- Upper Circuit
- ₹1,771.10
- Lower Circuit
- ₹1,449.10
- Day's Low - High
- ₹1,598.20 - ₹1,634.00
- 52 Week Low - High
- ₹1,548.00 - ₹1,851.20
Sun Pharmaceutical Historical Returns
- 1 Month Return
- -6.82 %
- 3 Month Return
- -5.64 %
- 1 Year Return
- -7.5 %
- 3 Year Return
- + 59.8 %
- 5 Year Return
- + 164.19 %
Sun Pharmaceutical Fundamentals
as on February 2, 2026 at 1:43 pm IST
Market Cap
₹3,86,316.92 Cr
Return on Equity (ROE)
17.83
PE Ratio (TTM)
35.39
Return on capital employed (ROCE)
16.29
Industry PE ratio
40.1
Beta (LTM)
0.7
P/B Ratio
17.11
Dividend Yield
0.92
PEG Ratio
-16.08
Quarterly Earnings Growth YOY
16.57
EPS (TTM)
45.76
Sector
Pharmaceuticals
Book Value
301
Technical Analysis
Bearish
View Technical Analysis
Sun Pharmaceutical Stock Valuation
as on February 2, 2026 at 1:43 pm IST
Sun Pharmaceutical in the last 5 years
Lowest (19.47x)
March 23, 2020
Today (35.39x)
February 1, 2026
Industry (40.10x)
February 1, 2026
Highest (184.63x)
August 28, 2020
Today’s Price to Earnings Ratio: 35.39x
Sun Pharmaceutical Industries Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Sun Pharmaceutical with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 3,86,316.92 | 32.84% | 0.52 | 10,980 | 52,578 | |
| HOLD | 1,60,767.77 | 14.13% | 0.50 | 2,191 | 9,360 | |
| BUY | 1,35,280.03 | 42.17% | 0.66 | 1,911 | 11,516 | |
| BUY | 59,681.82 | -1.19% | 0.78 | 1,429 | 15,261 | |
| HOLD | 30,221.27 | -2.53% | 0.53 | 698 | 5,616 |
Analyst Recommendation on Sun Pharmaceutical Stock
Based on 38 analysts
89.47%
Buy
0.00%
Hold
10.53%
Sell
Based on 38 analysts, 89.47% of analysts recommend a 'BUY' rating for Sun Pharmaceutical. Average target price of ₹1968.76
Source: S&P Global Market Intelligence
Sun Pharmaceutical Share Price Target
Get share price movements and forecasts by analysts on Sun Pharmaceutical.
What analysts predicted
22.28%UPSIDE
Target Price
₹1968.76
Current Price
₹1623
Analyzed by
38 Analysts
High
₹2450
Target
₹1968.76
Low
₹1575
Sun Pharmaceutical target price ₹1968.76, a slight upside of 22.28% compared to current price of ₹1623. According to 38 analysts rating.
Source: S&P Global Market Intelligence
Sun Pharmaceutical Stock’s Investor Sentiment and Interest
Investment in Sun Pharmaceutical Industries Ltd Shares on INDmoney has grown by 37.37% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:37.37% versus previous 30 day period
Search interest for Sun Pharmaceutical Industries Ltd Stock has increased by 28% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:28% versus previous 30 day period
Sun Pharmaceutical Industries Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Sun Pharmaceutical Industries Ltd Annual Profit & Loss
Figures in Rupees Crores
Sun Pharmaceutical Industries Ltd Cash Flow
Figures in Rupees Crores
Sun Pharmaceutical Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Sun Pharmaceutical Stock
Check out the Mutual Funds with significant holdings in Sun Pharmaceutical.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 ICICI Prudential Value Fund Direct Plan Growth | 4.57% | 16298476 | |
ICICI Prudential Equity & Debt Fund Direct Plan Growth | 4.7% | 13561085 | |
ICICI Prudential Large Cap Fund Direct Plan Growth | 2.61% | 11932663 | |
ICICI Prudential India Opportunities Fund Direct Growth | 3.72% | 7527584 | |
 HDFC Balanced Advantage Fund Direct Plan Growth Option | 1.18% | 7414889 |
Sun Pharmaceutical Corporate Actions
View detailed summary of the earnings and dividend history of Sun Pharmaceutical.
Sun Pharmaceutical Industries Ltd Earnings Results
Sun Pharmaceutical Industries Ltd’s net profit jumped 16.03% since last year same period to ₹3,368.81Cr in the Q3 2025-2026. On a quarterly growth basis, Sun Pharmaceutical Industries Ltd has generated 8.05% jump in its net profits since last 3-months.
Read More about Earnings ResultsSun Pharmaceutical Industries Ltd Dividends January,2026
In the quarter ending December 2025, Sun Pharmaceutical Industries Ltd has declared dividend of ₹11.00 per share on 31 Jan 2026 - translating a dividend yield of 1.69%.
Read More about Dividends
Sun Pharmaceutical News & Key Events
Today's Timeline - 02 February
09:04 AM
-Sun Pharma reports 16% YoY profit growth in Q3FY26, driven by new product launches and strong market performance.
Indices Featuring Sun Pharmaceutical Stock
Check stock indices that include Sun Pharmaceutical.
Insights on Sun Pharmaceutical Industries Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 4 quarters, 2.14K Cr → 3.36K Cr (in ₹), with an average increase of 13.3% per quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 13.57K Cr → 16.09K Cr (in ₹), with an average increase of 5.5% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 159.4% return, outperforming this stock by 99.6%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 54.48% of holdings in Dec 2025 quarter
- NO EFFECT
Against Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 26.1% return, outperforming this stock by 33.6%
NEGATIVE IMPACTMF Holding Down
Mutual Funds have decreased holdings from 12.41% to 12.09% in Dec 2025 quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 16.55% to 16.12% in Dec 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 8.73% to 8.58% in Dec 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, SUNPHARMA stock has moved down by -1.8%
Sun Pharmaceutical Stock Futures & Options Contracts
View the latest movement in Sun Pharmaceutical Futures & Options, including strike prices, expiry dates, and percentage changes.
Sun Pharmaceutical Options
Sun Pharmaceutical Futures
About Sun Pharmaceutical Industries Ltd
Sun Pharma's branded formulations include products for cardiovascular, central nervous system, gastroenterology, ophthalmology, and dermatology. Sun Pharma's specialty generics include injectables, inhalants, and complex products. Sun Pharma's API portfolio includes products for a range of therapeutic areas, including cardiovascular, central nervous system, gastroenterology, and dermatology.
Sun Pharma's top products include Modalert, a generic version of Modafinil for treating sleep disorders; Glocip, a generic version of Glipizide for treating diabetes; and Doxicip, a generic version of Doxycycline for treating bacterial infections. Sun Pharma's popular brands include Revital, a multivitamin supplement; Tazret, a topical retinoid for treating psoriasis; and Olmecip, a generic version of Olmesartan for treating hypertension.
Revenue: ₹15,469.07Cr as on December 2025 (Q3 FY26)
Net Profit: ₹3,401.09Cr as on December 2025 (Q3 FY26)
Listing date: 08 Feb, 1995
| Organisation | Sun Pharmaceutical Industries Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs
What is Sun Pharmaceutical share price today?
Sun Pharmaceutical share price today stands at ₹1623 as on . Sun Pharmaceutical share today touched a day high of ₹1634 and a low of ₹1598.2.
What is the 52 week high and 52 week low range for Sun Pharmaceutical share?
Sun Pharmaceutical touched a 52 week high of ₹1851.2 and a 52 week low of ₹1548. Sun Pharmaceutical share price today i.e. is trending at ₹1623, which is -12.33% down from its 52 week high and 4.84% up from its 52 week low.
What is Sun Pharmaceutical's market capitalisation today?
Sun Pharmaceutical market capitalisation is ₹3,86,316.92 Cr as on .
How to buy Sun Pharmaceutical shares?
To buy Sun Pharmaceutical shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for SUNPHARMA or Sun Pharmaceutical Industries Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Sun Pharmaceutical shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Sun Pharmaceutical trading volume today?
Sun Pharmaceutical trading volume is 18.44L as on . This means that 18.44L shares of Sun Pharmaceutical were bought and sold on the stock market during today's trading session.